(10)The prudent use of antimicrobials is a cornerstone in addressing antimicrobial resistance (AMR). Switzerland and the EU are actively combating AMR through action plans based on the ‘One Health’ approach. Switzerland will apply the same provisions as those set out in Article 107 (with the exception of paragraph 6), in conjunction with Article 37(5) of Regulation (EU) 2019/6 of the European Parliament and of the Councilnote, as regards the rules on the use of antimicrobial medicinal products in productive animals, the prohibition of use in productive animals of designated antimicrobials or of groups of antimicrobials reserved for the treatment of certain infections in humans, and for controls of imports of animals and products of animal origin originating in third countries. Trade in animals and products of animal origin between Switzerland and the European Union may therefore be conducted without an accompanying official certificate to demonstrate compliance with the restrictions applicable to the use of antimicrobial medicinal products until 1 July 2028. These provisions should be added in Appendices 2, 3, 5, 6 and 10 of Annex 11 to the Agreement.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.